Qihuan Xu, MD
Titles
Professor of Infectious Diseases
Professor of Liver Diseases
Specialist Officer of Liver Diseases Department of Internal Medicine
Research Interests
· Hepatitis B, Hepatitis C, viral Hepatitis
· Anti-viral treatment
· Liver failure
· Liver cirrhosis
· Infection of the central nervous system
Dr. Xu has engaged in the field of infectious diseases for 30 years. His work focuses on viral hepatitis treatment. Dr. Xu has conducted numerous FDA approved clinical trials to evaluate the safety and effectiveness of new anti-viral drugs for hepatitis B and hepatitis C. He currently serves as the Specialist Officer of Liver Diseases Department of Internal Medicine. Dr. Xu’s other research interests include the management of liver failure, liver cirrhosis and Infection of the central nervous system, such as cryptococcal meningitis.
Education and Experience
1980.9-1986.7 MD, Medical Science Department of the Sun Yat-sen University
1986.7-1993.11 Residency, the Third Affiliated Hospital of the Sun Yat-sen University
1986 Residency, the First Affiliated Hospital of Sun Yat-sen University
1993.12-1999.11 Attending Doctor, the Third Affiliated Hospital of Sun Yat-sen University
1999.12-2009.11 Associate Professor, the Third Affiliated Hospital of Sun Yat-sen University
2009.12 Professor, the Third Affiliated Hospital of Sun Yat-sen University
1999.4-1999.7 Fellowship, Margaret Hospital of Hongkong
Publications
1. Qihuan Xu, Xingfei Pan, Xin Shu,Hong Cao,Xuejun Li,Ka Zhang, Jianxi Lu, Yong Zou, Xueling Li, Hongcan Liu, Yeqiong Zhang, Daofeng Yang, Qin Ning, Guanxin Shen, Gang Li .Increased interleukin-32 expression in chronic hepatitis B virus-infected liver Joural of Infection 2012, 65: 336-342.
2. XU Qihuan, ZHANG Xiaohong,XIE Dongying，et al. Study on the special cellular immunoreactions of PBMC in the chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine. Chinese Journal of experimental and clinical virology，2007，21（4）:334-336
3. XU Qihuan, ZHANG Xiaohong, XIE Dongying，et al. A study of the dosage and efficacy in the chronic hepatitis B patients treated with recombinant hepatitis B vaccine combined with interferon alfa-1b . Chinese Journal of infectious disease.2008，26（3）：163-167.
4. XU Qihuan, SHU Xin, CHEN Lubiao, et al. Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B. Chinese Journal of experimental and clinical virology, 2008；22（6）：422-424
5. Xu Qi-huan, Chen Ni, Shu Xin, et al. The efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral loading.(abstract) Hepatology, 2009, 50(4suppl):530A
6. X.Qihuan, C.Lubiao, S.Xin, et al. The short-term efficacy of antiviral treatment in patients with acute-on-chronic hepatitis B liver failure. Journal of Hepatology, 2010, 52(1suppl):1014
7. Xudong Liu , Qihuan Xu,Wei Chen, et al. Hepatitis B virus DNA-induced carcinogenesis of human normal liver cells by virtue of nonmethylated CpG DNA. Oncology Reports,2009;21(4):941-947
8. ZHANG Ka, XU Qihuan, CHEN Lubiao, et al. Correlation of serum chemokine RANTES level with biochemical indices in patients with chronic hepatitis B . Chinese Journal of experimental and clinical virology,2009；23（3）：188-190 (Corresponding author)
9. CHEN Lubiao ,HUANG Haihui, SHU Xin, XU Qihuan, et al. Pathological study of liver biopsy from 156 patients clinically diagnosed with mild chronic hepatitis B based on current guideline. Chinese Journal of experimental and clinical virology, 2009；23（2）：138-140 (Corresponding author)
10. Ka Zhang, Xingfei Pan, Xin Shu, Hong Cao,Lubiao Chen, Yong Zou, Hong Deng, Gang Li, Qihuan Xu. Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cellular Immunology, 2013,282:113-116 (Corresponding author)
Contact
Division of Infectious Diseases,
The Third Affiliated Hospital of Sun Yat-sen University
600 Tianhe Road, Guangzhou, 510630
Phone: 00862085253179，00862085253059
